Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models (Q43518801)

24 November 2017

Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models (English)

1 reference

24 November 2017

Qin Wang

1

1 reference

24 November 2017

Xiao-jun Hou

2

1 reference

24 November 2017

Kun Cai

3

1 reference

24 November 2017

Tao Li

4

1 reference

24 November 2017

Yue-nan Liu

5

1 reference

24 November 2017

Wei Tu

6

1 reference

24 November 2017

Le Xiao

7

1 reference

24 November 2017

Shi-zhong Bao

8

1 reference

24 November 2017

Jing Shi

9

1 reference

24 November 2017

Xiang Gao

10

1 reference

24 November 2017

Hao Liu

11

1 reference

24 November 2017

Ren-mao Tian

12

1 reference

24 November 2017

Hui Wang

13

1 reference

24 November 2017

1 December 2010

1 reference

Canadian Journal of Microbiology

24 November 2017

1 reference

24 November 2017

56

1 reference

24 November 2017

12

1 reference

24 November 2017

1003-1010

1 reference

Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain.

24 November 2017

1 reference

Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli

21 January 2018

1 reference

Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection

21 January 2018

1 reference

Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections

21 January 2018

1 reference

Characterization of a Shiga toxin 1-neutralizing recombinant Fab fragment isolated by phage display system.

21 January 2018

1 reference

Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli

21 January 2018

1 reference

Enterohaemorrhagic Escherichia coli in human medicine

21 January 2018

1 reference

Infection by verocytotoxin-producing Escherichia coli

21 January 2018

1 reference

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

21 January 2018

1 reference

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

21 January 2018

1 reference

Phylogen of immunoglobulin structure and function. 3. Immunoglobulins of the chicken

21 January 2018

1 reference

Passive immunization using purified IgYs against infectious bursal disease of chickens in Pakistan

21 January 2018

1 reference

Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection

21 January 2018

1 reference

Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands

21 January 2018

1 reference

Monoclonal antibody to shiga toxin 1, which blocks receptor binding and neutralizes cytotoxicity

21 January 2018

1 reference

A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.

21 January 2018

1 reference

A nationwide case-control study of Escherichia coli O157:H7 infection in the United States

21 January 2018

1 reference

The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide

21 January 2018

1 reference

Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin.

21 January 2018

1 reference

Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome

21 January 2018

1 reference

Serum proteins and the livetins of hen's-egg yolk

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/W10-087

1 reference

24 November 2017

1 reference